Zobrazeno 1 - 10
of 50
pro vyhledávání: '"cell-free microRNA"'
Autor:
Ming-Jer Chen, An Hsu, Pei-Yi Lin, Yu-Ling Chen, Ko-Wen Wu, Kuan-Chun Chen, Tiffany Wang, Yu-Chiao Yi, Hsiao-Fan Kung, Jui-Chun Chang, Wen-Jui Yang, Farn Lu, Hwa-Fen Guu, Ya-Fang Chen, Shih-Ting Chuan, Li-Yu Chen, Ching-Hung Chen, Pok Eric Yang, Jack Yu-Jen Huang
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 76 (2023)
MicroRNAs (miRNAs) can regulate the expression of genes involved in the establishment of the window of implantation (WOI) in the endometrium. Recent studies indicated that cell-free miRNAs in uterine fluid and blood samples could act as alternative a
Externí odkaz:
https://doaj.org/article/4603991d1e15498a82b9ef2cc60d36ad
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 14, Iss C, Pp 211-222 (2016)
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Du
Externí odkaz:
https://doaj.org/article/c57fbe60de9b414bbf3acf55ee9c41a9
Autor:
Sara Carpi, Adriano Podestà, Beatrice Polini, Antonella Romanini, Maria Cristina Breschi, Paola Nieri
Publikováno v:
Pigment Cell & Melanoma Research. 32:486-499
Cutaneous melanoma is a skin cancer with increasing incidence. Identification of novel clinical biomarkers able to detect the stage of disease and suggest prognosis could improve treatment and outcome for melanoma patients. Cell-free microRNAs (cf-mi
Publikováno v:
Current Genomics
Pancreatic cancer (PaC) is one of the most lethal cancers, with an increasing global incidence rate. Unfavorable prognosis largely results from associated difficulties in early diagnosis and the absence of prognostic and predictive biomarkers that wo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yoko Koh, Matias A. Bustos, Jamie Moon, Rebecca Gross, Romela Irene Ramos, Suyeon Ryu, Jane Choe, Selena Y. Lin, Warren M. Allen, David L. Krasne, Timothy G. Wilson, Dave S. B. Hoon
Publikováno v:
Cancers; Volume 14; Issue 10; Pages: 2388
Prostate cancer (PCa) is the most common cancer in men. Prostate-specific antigen screening is recommended for the detection of PCa. However, its specificity is limited. Thus, there is a need to find more reliable biomarkers that allow non-invasive s
Autor:
Michaela B Kirschner, J James B Edelman, Steven Chuan-Hao Kao, Michael P Vallely, Nico eVan Zandwijk, Glen eReid
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
Cell-free microRNAs in plasma and serum have become a promising source of biomarkers for various diseases. Despite rapid progress in this field, there remains a lack of consensus regarding optimal quantification methods, reference genes and quality c
Externí odkaz:
https://doaj.org/article/3aa61044da5d43e3b97d433e2bbbd582
Publikováno v:
Frontiers in Genetics, Vol 4 (2013)
MicroRNAs are abundantly present and surprisingly stable in multiple biological fluids. These findings have been followed by numerous of reports revealing the clinical potential of using microRNA levels in body fluids as a biomarker of disease. Despi
Externí odkaz:
https://doaj.org/article/bad3217a6a934a26bb1493b9edcd30c3
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 14, Iss C, Pp 211-222 (2016)
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Du